RIQAS Point of Care – INR (Bi-Monthly)
The RIQAS Point of Care International Normalised Ratio (INR) EQA programme is designed to measure the effect of anticoagulant drugs such as warfarin as well as helping to diagnose a bleeding disorder, helping to estimate the severity of liver disease. This bi-monthly EQA programme will ensure early identification of system errors and implementation of any necessary corrective actions with minimum disruption.
Ready-to-use – We supply ready-to-use samples ensuring user convenience
Online User Portal – Offering an easy to use interface for programme registration, result submission and retrieval of reports
Easy to Interpret – Convenient traffic light system ensures reports are quick and easy to interpret
Customer Support – We support clients in improving performance while also providing support to commissioners in performance monitoring and management
Coordinator Reports – Allows group coordinators to see over a 12 month rolling window how each participant under their remit has preformed
Cat No | Kit Size | Frequency | Cycle Start | |
---|---|---|---|---|
RQ9189 | 1 x 300µl | Bi-Monthly | Coming Soon | |
Parameters
Tests
Role
Matrix
International Normalised Ratio (INR)
- Used to measure the effect of anticoagulant drugs such as warfarin
- Help diagnose a bleeding disorder; to help estimate the severity of liver disease
Whole Blood
Please note, product availability may vary country to country.
Continue Reading